Exclusive CRISPR licenses slow development of therapies, legal experts argue
(By Sharon Begley for STAT) The exclusive licenses granted to three for-profit companies on key discoveries about the revolutionary genome-editing technology
Read More(By Sharon Begley for STAT) The exclusive licenses granted to three for-profit companies on key discoveries about the revolutionary genome-editing technology
Read More(By Richard Harris for NPR) The U.S. patent office has delivered a potentially lucrative victory to bioengineer Feng Zhang of
Read MoreAetna and Humana are dropping their $37 billion merger bid ending a nearly two-year-long pursuit of a deal that would
Read More(By Michelle Andrews for Kaiser Health News) Every night, Jason Early attaches a catheter in his chest to a machine
Read MoreU.S. District Judge Amy Berman Jackson halted Anthem’s bid to acquire Cigna for $54 billion stating the deal between the
Read More(By Ayla Ellison for Becker’s Hospital Review) More than 30 states have adopted apology laws that prohibit a physician’s apology
Read More(By Susan Jaffe for NPR) A federal judge has accepted Medicare’s plans to try once more to correct a commonly
Read More(By Chad Terhune for California Healthline produced by Kaiser Health News) California officials have fined health care giant Kaiser Permanente
Read MoreOn Monday, a federal judge rejected a proposed merger between Aetna and Humana stating the deal would “be likely to
Read More(By Michelle Andrews for Kaiser Health News) Should gun owners have to share information with health professionals about their firearms
Read More